產(chǎn)品詳情
| 中文名稱:Elenbecestat;E2609 | 英文名稱:Elenbecestat;E2609 |
| CAS:1388149-30-1 | 純度規(guī)格: 98.0%HPLC |
| 產(chǎn)品類別: APIS |
2024-11-29
Elenbecestat;E2609
Elenbecestat;E2609
10MG/1800RMB;50MG/6000RMB
1800
98.0%HPLC
APIS
Elenbecestat;E2609;1388149-30-1
<span font-size:14px;background-color:#ffffff;"="" style="box-sizing: border-box; font-family: "Segoe UI", "Lucida Grande", Helvetica, Arial, "Microsoft YaHei", FreeSans, Arimo, "Droid Sans", "wenquanyi micro hei", "Hiragino Sans GB", "Hiragino Sans GB W3", FontAwesome, sans-serif; font-size: 16px; color: rgb(52, 73, 94);">Elenbecestat,also known as E2609 is a BACE1 inhibitor.
關(guān)鍵字： Elenbecestat;E2609;1388149-30-1
公司簡(jiǎn)介
Wuhan Sun-shine Bio-technology Corporation Limited (Shanghai Sun-shine Chemical Technology Corporation Limited) is a high-tech enterprise engaged inR&D and sales of related compounds of new drugs, specialty pharmaceutical API, advanced intermediates, organic synthetic masonry, and high-end reagents, etc. The special services we provide include: the technical development of chiral drugs, the development of an active molecular library.
| 成立日期 |
2012-07-20
（13年）
|
注冊(cè)資本 |
壹拾萬(wàn)元整
|
| 員工人數(shù) |
10-50人 |
年?duì)I業(yè)額 |
￥ 500萬(wàn)-1000萬(wàn) |
| 主營(yíng)行業(yè) |
中間體,醫(yī)藥原料 |
經(jīng)營(yíng)模式 |
工廠,定制,服務(wù) |